The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Palisade Bio Inc(NASDAQ:PALI) 
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing oral therapies that target diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal (GI) tract.
Website: https://senecabio.com/
Founded: 2005
CEO: Kenneth Carter
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Share this website to your friends
Palisade Bio Days Payable Outstanding ttm (DPO)
Palisade Bio Days Receivable Outstanding ttm (DSO)
Palisade Bio Days Inventory Outstanding ttm (DIO)
Palisade Bio Op Cashflow Per Share ttm
Palisade Bio Free Cashflow Per Share ttm
Palisade Bio Cash Per Share ttm
Palisade Bio P/S ratio ttm
Palisade Bio (GAAP) P/E ratio ttm
Palisade Bio P/B ratio ttm
No extra charts and metrics for this ticker.